Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)
One Minute Brief: Iran Talks, McDonald's Ups Pay
17:12 - Bloomberg briefs you on the top stories of the day including: the Iran nuclear talks, a pay rise for select McDonald's employees, and the U.K.'s pre-election debate.
  • Way Beyond the Deadline and No Agreement… Yet
  • Dollar Headed Higher After `Moment of Respite': Tihanyi
  • All Sides Determined to Avoid a Bad Deal: Thakur